P. Gusmorino
P. Gusmorino has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
I PINTER
5 shared publicationsBR SNOW
Department of Behavioral Medicine, Hospital for Joint Diseases Orthopaedic Institute, New York, NY 10003
3 shared publicationsA ROSENBLUM
2 shared publicationsAC JIMENEZ
Department of Behavioral Medicine, Hospital for Joint Diseases Orthopaedic Institute, New York, NY 10003
2 shared publicationsB SNOW
2 shared publicationsA JIMENEZ
1 shared publication
Latest Publications
- 1 April 2011
- Published by Elsevier in The Journal of Pain
- Vol. 12 (4) , P53
Lidoderm® effectiveness in reducing pain in post-operative unilateral knee replacements patients
- 1 April 2011
- Published by Elsevier in The Journal of Pain
- Vol. 12 (4) , P53
Lidoderm® effectiveness in reducing pain in post-operative unilateral knee replacements patients
- 1 June 2000
- Vol. 29 (6) , 443-6
Bupivacaine for postoperative pain relief at the iliac crest bone graft harvest site.
An inevitable side effect of iliac crest bone graft harvesting is postoperative pain at the donor site. Bupivacaine hydrochloride is a long-acting local anesthetic that is clinically effective for approximately 8 hours. The present study was undertaken to assess postoperative pain relief with locally injected bupivacaine at the iliac crest bone graft harvest site. Pain relief with locally injected bupivacaine or saline at the iliac bone harvest site using an indwelling catheter was studied in 13 patients in a prospective, double-blind, crossover study. Twelve patients had cervical diskectomy and arthrodesis with autograft and one patient had a triple arthrodesis of the foot. There were no statistically significant differences between patients given bupivacaine and patients given saline with respect to pain relief ratings and hip-pain ratings at rest and motion during the first 24-hour postoperative period and the second 24-hour postoperative period (Mann-Whitney test). The single diabetic patient who had a triple arthrodesis developed a wound infection at the catheter placement site. The number of patients was too small to draw conclusions about the differences in pain-medication requirements between patients undergoing single versus multiple diskectomies and fusions. In view of the lack of improvement in pain relief and the risk of infection, local administration of bupivacaine at the iliac bone harvest site is not recommended in its present form for postoperative analgesia.
- 1 June 2000
- Vol. 29 (6) , 443-6
Bupivacaine for postoperative pain relief at the iliac crest bone graft harvest site.
An inevitable side effect of iliac crest bone graft harvesting is postoperative pain at the donor site. Bupivacaine hydrochloride is a long-acting local anesthetic that is clinically effective for approximately 8 hours. The present study was undertaken to assess postoperative pain relief with locally injected bupivacaine at the iliac crest bone graft harvest site. Pain relief with locally injected bupivacaine or saline at the iliac bone harvest site using an indwelling catheter was studied in 13 patients in a prospective, double-blind, crossover study. Twelve patients had cervical diskectomy and arthrodesis with autograft and one patient had a triple arthrodesis of the foot. There were no statistically significant differences between patients given bupivacaine and patients given saline with respect to pain relief ratings and hip-pain ratings at rest and motion during the first 24-hour postoperative period and the second 24-hour postoperative period (Mann-Whitney test). The single diabetic patient who had a triple arthrodesis developed a wound infection at the catheter placement site. The number of patients was too small to draw conclusions about the differences in pain-medication requirements between patients undergoing single versus multiple diskectomies and fusions. In view of the lack of improvement in pain relief and the risk of infection, local administration of bupivacaine at the iliac bone harvest site is not recommended in its present form for postoperative analgesia.
- 1 September 1990
- Vol. 50 (2) , 200-204
MULTIDISCIPLINARY TREATMENT FOR A CHRONIC PAIN PATIENT RETURNING TO WORK - A CASE-REPORT
- 1 September 1990
- Vol. 50 (2) , 200-204
MULTIDISCIPLINARY TREATMENT FOR A CHRONIC PAIN PATIENT RETURNING TO WORK - A CASE-REPORT
- 1 September 1988
- Vol. 48 (2) , 176-181
BRAIN-STEM AUDITORY AND VISUAL EVOKED-POTENTIAL STUDIES IN PATIENTS WITH CHRONIC CERVICAL PAIN
Brainstem auditory evoked potential (BAEP) and visual evoked potential (VEP) studies were undertaken in 8 patients with chronic cervical pain associated with auditory and visual symptoms of more than 6 months duration. The purpose of the study was to ascertain possible central abnormalities, including posterior cervical sympathetic syndrome (Barre-Lieou syndrome), in their auditory and/or visual pathways. Patients who had been treated surgically for cervical pain were excluded from the study group. All patients had normal cervical radiographs and electromyographic findings. Six also had normal CT scans and myelograms. A criterion of the study was that abnormal results would be considered significant only if ophthalmological and/or otolaryngological work-ups failed to reveal an underlying organic abnormality. The TECA-TE 42 was used throughout the study, as well as the international Ten-Twenty System of Electrode Placement. The results showed no abnormalities in the latency, amplitude, or waveform morphology of the evoked potentials. BAEP and VEP studies do not appear to reveal central abnormalities of the auditory and visual pathways in this group of patients. However, in view of the small number of patients included in the study, no conclusions can be made with certainty and the study is continuing.
- 1 September 1988
- Vol. 48 (2) , 176-181
BRAIN-STEM AUDITORY AND VISUAL EVOKED-POTENTIAL STUDIES IN PATIENTS WITH CHRONIC CERVICAL PAIN
Brainstem auditory evoked potential (BAEP) and visual evoked potential (VEP) studies were undertaken in 8 patients with chronic cervical pain associated with auditory and visual symptoms of more than 6 months duration. The purpose of the study was to ascertain possible central abnormalities, including posterior cervical sympathetic syndrome (Barre-Lieou syndrome), in their auditory and/or visual pathways. Patients who had been treated surgically for cervical pain were excluded from the study group. All patients had normal cervical radiographs and electromyographic findings. Six also had normal CT scans and myelograms. A criterion of the study was that abnormal results would be considered significant only if ophthalmological and/or otolaryngological work-ups failed to reveal an underlying organic abnormality. The TECA-TE 42 was used throughout the study, as well as the international Ten-Twenty System of Electrode Placement. The results showed no abnormalities in the latency, amplitude, or waveform morphology of the evoked potentials. BAEP and VEP studies do not appear to reveal central abnormalities of the auditory and visual pathways in this group of patients. However, in view of the small number of patients included in the study, no conclusions can be made with certainty and the study is continuing.
- 1 March 1988
- Vol. 48 (1) , 52-61
MULTIDISCIPLINARY TREATMENT OF PHYSICAL AND PSYCHOSOCIAL DISABILITIES IN CHRONIC PAIN PATIENTS - A FOLLOW-UP REPORT
This report reviews the results of the first 2 1/2 years of a comprehensive multidisciplinary inpatient-outpatient treatment program for patients with chronic pain. Functional data indicate a 33 1/3% rate of return to work or involvement in work training programs, while self-report data indicate a 50% improvement rate. Future directions for research are suggested.
- 1 March 1988
- Vol. 48 (1) , 52-61
MULTIDISCIPLINARY TREATMENT OF PHYSICAL AND PSYCHOSOCIAL DISABILITIES IN CHRONIC PAIN PATIENTS - A FOLLOW-UP REPORT
This report reviews the results of the first 2 1/2 years of a comprehensive multidisciplinary inpatient-outpatient treatment program for patients with chronic pain. Functional data indicate a 33 1/3% rate of return to work or involvement in work training programs, while self-report data indicate a 50% improvement rate. Future directions for research are suggested.
- 1 March 1987
- Vol. 47 (1) , 72-77
THE USE OF CLONIDINE FOR THE TREATMENT OF MEPERIDINE WITHDRAWAL IN A MULTIDISCIPLINARY PAIN PROGRAM SETTING - A CASE PRESENTATION
The management of iatrogenic drug dependence in individuals with pain can be more difficult than the treatment of the pain itself. In addition to a multidisciplinary approach to the treatment of a patient with chronic pain, there is a need for a rapid, safe, and effective method of detoxification from opiate use. Clonidine HCl, a nonopiate, has been found, in this case presentation, to be a valuable option.
- 1 March 1987
- Vol. 47 (1) , 72-77
THE USE OF CLONIDINE FOR THE TREATMENT OF MEPERIDINE WITHDRAWAL IN A MULTIDISCIPLINARY PAIN PROGRAM SETTING - A CASE PRESENTATION
The management of iatrogenic drug dependence in individuals with pain can be more difficult than the treatment of the pain itself. In addition to a multidisciplinary approach to the treatment of a patient with chronic pain, there is a need for a rapid, safe, and effective method of detoxification from opiate use. Clonidine HCl, a nonopiate, has been found, in this case presentation, to be a valuable option.
- 1 March 1986
- Vol. 46 (1) , 22-30
INCIDENCE OF PHYSICAL AND PSYCHOSOCIAL DISABILITIES IN CHRONIC PAIN PATIENTS - INITIAL REPORT
Chronic pain is a leading health care problem with a wide range of physical and psychosocial outcomes. This report reviews the key intake findings of the first 227 patients admitted to a comprehensive inpatient/outpatient program for the treatment of chronic pain. Key trends in the data which suggest the different presentations of the chronic pain syndrome are highlighted and indications for future research are given.
- 1 March 1986
- Vol. 46 (1) , 22-30
INCIDENCE OF PHYSICAL AND PSYCHOSOCIAL DISABILITIES IN CHRONIC PAIN PATIENTS - INITIAL REPORT
Chronic pain is a leading health care problem with a wide range of physical and psychosocial outcomes. This report reviews the key intake findings of the first 227 patients admitted to a comprehensive inpatient/outpatient program for the treatment of chronic pain. Key trends in the data which suggest the different presentations of the chronic pain syndrome are highlighted and indications for future research are given.